2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

LiberaTx, Singapore

REVOLUTIONISING ORAL MEDICINES DELIVERY

Company Type

Biotechnology, Pharmaceutical

Startup

Company Name /LiberaTx

Company Website /www.liberatx.com

Startup year /2020

Amount of Capital /N/A

No. of workers /2

Stage

Startup

Presenter

Name /Sashi Kesavapany

Title /CEO & Co Founder

Email /sashi@liberatx.com

Telephone /

Fax /

Mobile /+65 91714163

About the Team

LiberaTx is a start-up company spun out from technology developed in the laboratory of A/Prof Joachim Loo from the School of Material Sciences Engineering at Nanyang Technological University (NTU). Joachim is the founder and Sashi is the CEO and Co-Founder.

Brief Description of main products or services

LiberaTx reformulates existing marketed pharmaceuticals with poor bioavailability profiles to improve treatment outcomes in patients. Using our proprietary technology, the scientific concept is to exploit the floatability of the particles to achieve extended release and controlled release profiles of drugs. In addition, the technology allows multiple drug loading in single or multiple compartments of the nanoparticles which can be tuned for appropriate release. Our first 2 assets are positioned to enter Phase2A clinical trials upon regulatory approval, for the symptomatic treatment of Parkinson’s Disease for which we are seeking funding support for.

Contact Person

Name /Sashi Kesavapany

Phone /+65 91714163

Email /sashi@liberatx.com